Apellis Pharmaceuticals, Inc.
APLSCIK 0001492422 · Every Form 4 filed by insiders at this issuer.
Filings
54
Latest Mar 20, 2024
Unique insiders
16
Showing
4 of 54
Page 2
Top insiders
Most active reporters at Apellis Pharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| DeLong Mark Jeffrey | Officer | 5 |
| Deschatelets Pascal | Officer | 5 |
| Eisele Jeffrey | Officer | 5 |
| Francois Cedric | OfficerDirector | 5 |
| Lewis Karen | Officer | 5 |
| Sullivan Timothy Eugene | Officer | 5 |
| Watson David O. | Officer | 5 |
| Nicholson Nur | Officer | 4 |
| Townsend Adam J. | Officer | 4 |
| Chopas James George | Officer | 3 |
All filings
54 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Jan 2, 2024 | Dunlop A. Sinclair Director | A | 3,341 | $0.00 | $0 | |
| Jan 2, 2024 | Chan Gerald Director | A | 3,341 | $0.00 | $0 | |
| Jan 2, 2024 | O'Brien Stephanie Monaghan Director | A | 3,341 | $0.00 | $0 | |
| Jan 2, 2024 | FONTEYNE PAUL R. Director | A | 3,341 | $0.00 | $0 |
Showing 51–54 of 54
PrevPage 2 of 2
Real-time Form 4 intelligence. Smarter insider tracking.